ConductScience.org, home

Paper3978648

Disposition of mitoxantrone in cancer patients.

Alberts DS and 4 others. Cancer Res, 1985. Cited by 79 papers, by iCite.

Cite this record

ConductScience Library. Disposition of mitoxantrone in cancer patients. Papers, record 3978648. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3978648

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Disposition of mitoxantrone in cancer patients.
PubMed
Journal
Cancer Res
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
3.19
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alberts DSD S
2Peng YMY M
3Leigh SS
4Davis TPT P
5Woodward DLD L

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnthraquinonesMajor topic
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Carbon Radioisotopes
Chromatography, High Pressure Liquid
Female
Humans
Kinetics
Male
Mitoxantrone
Tissue Distribution

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 17094NCI NIH HHSUnited StatesP01CA017094PubMed and NIHNIH RePORTER
CA 23074NCI NIH HHSUnited StatesP30CA023074PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
38904799Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer.Eur J Clin Pharmacol2024https://conductscience.org/library/papers/38904799PubMed
26966579Management of Multiple Sclerosis in the Breastfeeding Mother.Mult Scler Int2016https://conductscience.org/library/papers/26966579PubMed
24357218Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.Pediatr Blood Cancer2014https://conductscience.org/library/papers/24357218PubMed
22886782Application of Fenton, photo-Fenton, solar photo-Fenton, and UV/H2O2 to degradation of the antineoplastic agent mitoxantrone and toxicological evaluation.Environ Sci Pollut Res Int2013https://conductscience.org/library/papers/22886782PubMed
22451016A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding.AAPS J2012https://conductscience.org/library/papers/22451016PubMed
16430310Mass balance studies, with a focus on anticancer drugs.Clin Pharmacokinet2006https://conductscience.org/library/papers/16430310PubMed
15089110Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs2004https://conductscience.org/library/papers/15089110PubMed
11986955Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia.Leukemia2002https://conductscience.org/library/papers/11986955PubMed
9310249High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule.Br J Cancer1997https://conductscience.org/library/papers/9310249PubMed
9083333Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice.Br J Cancer1997https://conductscience.org/library/papers/9083333PubMed
8820798Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia.Drugs Aging1996https://conductscience.org/library/papers/8820798PubMed
8699238Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data.J Neurooncol1996https://conductscience.org/library/papers/8699238PubMed
3948308Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3948308PubMed
3719894The clinical pharmacology of mitozantrone.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3719894PubMed
3568271Pharmacokinetics of ametantrone acetate (NSC-287513).Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3568271PubMed
3397768Human central nervous system and plasma pharmacology of mitoxantrone.J Neurooncol1988https://conductscience.org/library/papers/3397768PubMed
2924379Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone).Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2924379PubMed
2185907Pharmacokinetics and metabolism of mitoxantrone. A review.Clin Pharmacokinet1990https://conductscience.org/library/papers/2185907PubMed
1760859Clinical pharmacokinetics of mitoxantrone in hyperthermic, isolated perfusion of the leg.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1760859PubMed
1711446Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.Drugs1991https://conductscience.org/library/papers/1711446PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3978648

GET https://conductscience.org/api/papers/v1/3978648/cited_by?page=2